Research suggests compound administered during some bone marrow transplants elevates risks

Research conducted at Oregon Health & Science University's Vaccine and Gene Therapy Institute may spur debate about the risks associated with administering a specific compound in some forms of bone-marrow transplantation. The research is published in the current edition of Cell Host and Microbe.

Read the whole article on Physorg

More from Physorg